71,307 Shares of DENTSPLY SIRONA Inc. $XRAY Acquired by Inspire Investing LLC

Inspire Investing LLC acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm acquired 71,307 shares of the medical instruments supplier’s stock, valued at approximately $632,000.

Several other hedge funds have also recently modified their holdings of the company. MBL Wealth LLC purchased a new stake in shares of DENTSPLY SIRONA in the third quarter worth $119,000. Skylands Capital LLC increased its stake in DENTSPLY SIRONA by 12.6% in the 3rd quarter. Skylands Capital LLC now owns 199,150 shares of the medical instruments supplier’s stock worth $1,764,000 after acquiring an additional 22,300 shares during the last quarter. Great Hill Capital LLC increased its stake in DENTSPLY SIRONA by 7.8% in the 3rd quarter. Great Hill Capital LLC now owns 1,749,065 shares of the medical instruments supplier’s stock worth $15,497,000 after acquiring an additional 126,680 shares during the last quarter. IFP Advisors Inc raised its holdings in shares of DENTSPLY SIRONA by 244.4% in the 3rd quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 3,950 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC raised its holdings in shares of DENTSPLY SIRONA by 178.5% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 80,715 shares of the medical instruments supplier’s stock valued at $715,000 after acquiring an additional 51,738 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Leerink Partners dropped their price target on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research report on Wednesday, October 14th. BMO Capital Markets decreased their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday, September 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Barclays lifted their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Finally, Piper Sandler cut their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, October 9th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.62.

DENTSPLY SIRONA Trading Down 0.8%

NASDAQ XRAY opened at $9.53 on Friday. The firm has a market capitalization of $1.90 billion, a PE ratio of -3.47, a P/E/G ratio of 1.23 and a beta of 0.87. The stock’s 50 day moving average is $9.70 and its 200 day moving average is $11.34. DENTSPLY SIRONA Inc. has a twelve month low of $8.32 and a twelve month high of $14.76. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The business had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.39 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.